Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world, after China, the market is characterized by a huge demand for anti-diabetic drugs. Huge increase in the number of diabetic patients promotes growth of the anti-diabetics pharmaceutical industry. The incidence of diabetes is higher in developed countries because of unhealthy lifestyles . Development of new and innovative drugs is also providing a boost to the market. Comprehensive health insurance coverage fuels the market growth by raising the affordability among patients. Increasing aging population in India increases the prevalence of diabetes, which in turn gives a boost to the drugs market. However Price regulation in the insulin market and competition from alternative diabetes treatment hinders the growth of Anti-diabetic pharmaceuticals market in India. In spite of substantial demand-supply gap in the insulin market, foreign manufacturers and importers are facing a huge price challenge. Now-a-days People are becoming more aware of diabetes ,and are trying to move away from unhealthy sedentary lifestyles. Increasing awareness on part of the consumers are making them incorporate more physical exercises and avoid junk food. Such consciousness on part of the consumers is decreasing the growth of diabetes, which is limiting the growth of the anti-diabetic pharmaceutical market to some extent. The Indian Government, on its part, has introduced some diabetes control programmes. Various initiatives taken by the government is providing a boost to this market. The market is expected to exhibit steady growth over the next few years.
Table of Contents
Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2011-12 - 2014-15), Inflation Rate: Monthly (Dec 2014-Jan 2015 - Mar 2015-Apr 2015) Slide 3: Gross Fiscal Deficit: Monthly (Feb 2014 - Jul 2014), Exchange Rate: Monthly (Dec 2014 - May 2015) Slide 4: Lending Rate: Annual (2011-12 - 2014-15), Trade Balance: Annual (2011-12 - 2014-15), FDI: Annual (2009-10 - 2013-14) Introduction Slide 5: Types of diabetes Slide 6: Classification of the diabetes market Slide 7: Classes of anti-diabetic drugs Market Overview Slide 8: Global Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth Slide 9: Indian Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth Slide 10: Global Diabetes map Drivers & Challenges Slide 11: Summary Slide 12-15: Key Drivers Slide 16-17: Key Challenges Government Initiatives Slide 18: Government programmes Market Value Chain Slide 19: Pharmaceutical Value Chain Slide 20: Multistage Drug Development Process Regulation and Patents Slide 21: Drug regulations Slide 22-23: Drugs approved for marketing in India Slide 24: Regulatory Frameworks Competitive Landscape Slide 25: Competition Overview Slide 26: Porter's Five Forces Analysis Slide 27-31: Competitive benchmarking Slide 32-71: Major Public Player Strategic Recommendations Slide 72: Key Strategic Recommendations Appendix Slide 73: Appendix Slide 74: Sources of information
List of Tables
Regulation and Patents 1. Drugs Approved for Marketing in India Competitive Landscape 1. Public Trading Comparables (FY 2014) - Top 3 Companies 2. Company Profiles (All Companies) a. Company Information (All Companies) b. Products and Services (All Companies) c. Key People (All Companies) d. Key Financial Performance Indicators (All Companies) e. Key Ratios (All Companies) f. Business Highlights (All Companies) Appendix 1. Appendix 2. Sources of Information
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.